The seminal Diabetes Control and Complications Trial (DCCT) in 1992 and the UK Prospective Study both demonstrated that tight glucose control, which is facilitated by frequent self-monitoring of glucose, halts or appreciably slows the progression of diabetic complications.
The Need for New Devices
Diabetes mellitus has reached epidemic proportions in the United States and more recently worldwide. The morbidity and mortality associated with diabetes is anticipated to account for a substantial proportion of health care expenditures. Although there are many devices available that help patients manage the disease, FDA recognizes the need for new and improved devices for treatment of diabetes. Source: FDA